2020 BIO CEO & Investor Conference Attendee List

as of January 29, 2020

TITLE/INVESTOR TYPE COMPANY COUNTRY

VC/Corporate VC 3E Bioventures United States

Family Office 3i Fund United States

Family Office A C Binder Corp United States

Founder and Chair Ab Studio United States

Director AbbVie United States

VC/Corporate VC Accelmed Partners United States

VC/Corporate VC Aceras Partners United States

Executive Vice President, Chief Business Officer Achillion Pharmaceuticals United States

VC/Corporate VC Acorn Bioventures United States

Principal Financial Officer Actinium Pharmaceuticals United States

Chairman and CEO Actinium Pharmaceuticals United States

Family Office Acuitas Capital Family Office United States

VC/Corporate VC Aditum Bio United States

VC/Corporate VC Adjuvant Capital United States

CEO Aetion United States

Hedge/Mutual Funds (PM, Buy-Side Research) Affinity Asset Advisors United States

Family Office AFUND United States

CEO Ai Cure Technologies United States

VC/Corporate VC AIG United States

CEO AIMM Therapeutics Netherlands

VC/Corporate VC Aisling Capital United States

CEO AiVita Biomedical United States

Family Office Aleph Capital United States

Associate Alexandria Venture Investments United States

Head of LaunchLabs Alexandria Venture Investments United States

Family Office Alignment Ventures United States

Investor Alliance for Aging Research United States

Venture Philanthropy Alliance for Cancer Gene Therapy United States

Angel Investing Alnitak capital United States

SVP, Head of Medical Affairs Alnylam Pharmaceuticals United States

Chief Executive Officer Alpha Cancer Technologies Canada

Chairman Alpha Cancer Technologies Canada

VP of Business Development Alpine Immune Sciences United States

Chief Financial Officer Altimmune United States

President and CEO Altimmune United States

Chief Scientific Officer Altimmune United States

PRESIDENT/CEO ALTuCELL United States

CEO Alveo Technologies United States

President Alveo Technologies United States

Chief Executive Officer American Gene Technologies International United States

CEO AMNICELL United States

Founder and Chief Science Officer AMNICELL United States

VC/Corporate VC Amplitude Ventures Canada

President & CEO Amplyx Pharmaceuticals United States

CEO Amygdala Neurosciences United States

Chief Executive Officer Anavex Life Sciences United States

Investor Andreessen Horowitz United States

President & CEO AnGes Inc. Japan

Founder and CBO AnHeart Therapeutics United States

Co-founder and CEO Anima Biotech United States

Hedge/Mutual Funds (PM, Buy-Side Research) Anson Funds Canada

Vice President Aon Risk Solutions United States

Account Executive Aon Risk Solutions United States

Investment Officer Apex-Brasil Brazil

CEO Aprinoia Therapeutics Taiwan

President and Executive Director Aptorum Group Hong Kong

Senior Associate Aptorum Group Hong Kong

Head of Research & Development Aptorum Group Hong Kong

Chief Financial Officer Aptose Biosciences United States

Chairman & CEO Aptose Biosciences United States

Chief Business Officer Aptose Biosciences United States

CFO Aracari Biosciences United States

Family Office Aracle Capital United States

CEO Arch Biopartners Canada

VC/Corporate VC Arch Venture Partners United States

Founder, President & CEO Arcturus Therapeutics United States

Director, IR/PR/Marketing Arcturus Therapeutics United States

President and Chief Executive Officer Arena Pharmaceuticals United States

VC/Corporate VC Arix Bioscience United States

CEO ARJUNA Therapeutics Spain

Hedge/Mutual Funds (PM, Buy-Side Research) Armistice Capital United States

Royalty/Debt Financing Arsenal Capital Partners United States

CEO Aruvant Sciences, Inc. United States

Chief Business Officer Ascendia Pharmaceuticals United States

CEO Ascendia Pharmaceuticals United States

Sell-Side Research Ascendiant Capital Markets United States

Investment Bank Ascendiant Capital Markets United States

Hedge/Mutual Funds (PM, Buy-Side Research) Ashford Capital Management United States

Chief Business Officer Ashvattha Therapeutics United States

Chairman, CEO & President Ashvattha Therapeutics United States

Founder/CEO Asimov United States

Hedge/Mutual Funds (PM, Buy-Side Research) Aspire Capital United States

VC/Corporate VC Asset Management Ventures United States

VC/Corporate VC Astellas Pharma US United States

Angel Investing Astute Capital United States

VC/Corporate VC ATEM Capital United States

VC/Corporate VC Atheneos Ventures United States

CFO and GC Atossa Genetics United States

Chief Financial Officer Atreca United States

IR Atreca United States

Chief Strategy Officer Atreca United States

Chief Financial Officer aTyr Pharma United States

President, CEO aTyr Pharma United States

Royalty/Debt Financing AUGC Netherlands

Investor Aurora Capitals United States

Managing Director, LS Client Solutions Avalere Health United States

Head, Client Solutions Avalere Health United States

President and CEO Avenue Therapeutics United States

Hedge/Mutual Funds (PM, Buy-Side Research) Ayrton Capital United States

President and CEO Azitra United States

Chief Operating and Business Officer AZTherapies United States

Director, Business Development AZTherapies United States

VC/Corporate VC Baidu United States

Financial Advising Bank of America Merrill Lynch United States

Investor Barclays United States

Hedge/Mutual Funds (PM, Buy-Side Research) Bathala Capital United States

Family Office Beacon Capital United States

COO Beacon Pharmaceutical United States

Investment Bank Berenberg Capital Markets United States

Senior Manager/Area Manager UK Berlin Partner für Wirtschaft und Technologie GmbH Germany

Hedge/Mutual Funds (PM, Buy-Side Research) Bifrost Capital United States

Family Office Bigger Capital Fund United States

Family Office BIMA Capital United States

VC/Corporate VC Bioadvance United States

CEO Bioasis Technologies United States

Corporate Account Manager BioCentury United States

President & CEO Biocept United States

Investor Biocoast Capital United States

Angel Investing BioIDEA United States

Angel Investing BioIdeations United States

Hedge/Mutual Funds (PM, Buy-Side Research) BioIdeations United States

Senior Membership and BD Manager Bioindustry Association (BIA) United Kingdom

VC/Corporate VC BioInnovation Capital United States

VP Research and Development BioLineRx Israel

CEO BioLineRx Israel

President & CEO BioMarker Strategies United States

Hedge/Mutual Funds (PM, Buy-Side Research) Biondo Investment Advisors United States

VC/Corporate VC Bios Partners United States

Angel Investing BioSense Global United States

Family Office Biotech Alliances International United States

Family Office Biotech Investment Group United States

CEO and Co-founder BioVersys AG Switzerland

Family Office Black Diamond Advisors United States

Senior Health-Care Policy Analyst Bloomberg Intelligence United States

Hedge/Mutual Funds (PM, Buy-Side Research) Blue Rock Capital Advisors United States

Angel Investing Bohe Angel Fund China

VC/Corporate VC Bojian Capital United States

CEO Boundless Bio United States

VC/Corporate VC Brace Pharma Capital United States

Chief Operating Officer & Chief Medical Officer BrainStorm Cell Therapeutics United States

President & CEO BrainStorm Cell Therapeutics United States

Chief Executive Officer Breakthrough Genomics United States

Business Development Brex United States

Account Executive Brex United States

Investment Bank Bridge Bank United States

Royalty/Debt Financing Bridge Bank United States

Associate Director, External Operations Bristol-Myers Squibb United States VP, Hematology, Cell Therapy & Translational Medicine Bristol-Myers Squibb United States

Angel Investing Brock Capital Group United States

Sell-Side Research Brookline Capital Markets United States

Sell-Side Research Bryan, Garnier & Co. United States

Sell-Side Research BTIG United States

Venture Partner BVCF United States

President & CEO Caladrius Biosciences United States

Vice President of IR & Corporate Communications Caladrius Biosciences United States

President & CEO California Life Sciences Association United States

Sell-Side Research Canaccord Genuity United States

Chief Executive Officer Cancer Prevention Pharmaceuticals United States

Sell-Side Research Cantor United States

Investor Capital Family Office United States Director, Advanced Therapy Medicinal Product Development Cardinal Health United States

Chairman & CEO Catalyst Pharmaceuticals United States

COO & CSO Catalyst Pharmaceuticals United States

Bussiness developer Catalyze NA Netherlands

President Catalyze NA Netherlands

Family Office Cato BioVentures United States

Family Office Caxton Alternative Management United States

managing director Cedrus Group Hong Kong

Executive Vice President & Chief Scientific Officer Celavie Biosciences United States

VP Technology Celavie Biosciences United States

CEO/President Celavie Biosciences United States

Chief Executive Officer Cell Care Therapeutics United States

Chief Executive Officer Celmatix United States

Public Relations Contact Cel-Sci United States

Chief Executive Officer CEL-SCI United States

Partner Centerview Partners United States

CEO Cerevance United States

CEO Cernostics United States

CEO CerSci Therapeutics United States

Angel Investing Chaperone Investment United States

Sell-Side Research Chardan Capital Markets United States

Family Office Charlestown Capital United States

Hedge/Mutual Funds (PM, Buy-Side Research) Chartwell United States

Chief Executive Officer ChemioCare United States

Family Office Chronon Capital United States

Life Sciences Underwriter Chubb United States

Investor Church Pension Fund United States

Hedge/Mutual Funds (PM, Buy-Side Research) CJ Seligman & Co. United States

Chief Executive Officer Clearside Biomedical United States

VC/Corporate VC CLI United States

Director Clinical Network Services United Kingdom

President & CEO CODA Biotherapeutics United States

Director, Investor Relations CohBar United States

Chief Operating Officer CohBar United States

CEO CohBar Inc. United States

Co-Founder and CSO Concarlo Holdings United States

Commercial Attaché of Lithuania to the USA Consulate General of Lithuania United States

President Correlia Biosystems United States

VC/Corporate VC Cowen Healthcare Investments United States

Angel Investing Cowin Venture China

Hedge/Mutual Funds (PM, Buy-Side Research) Crescent Capital Ventures United States

CEO / CMO Cristal Therapeutics Netherlands

CFO Cristal Therapeutics Netherlands

VC/Corporate VC Crosswave Management United States

Investor CRV United States

Investor CSC Leasing United States

VC/Corporate VC CTI Capital Gestion United States

VC/Corporate VC CTTQ Pharmaceutical Group United States

Angel Investing CyberMed Holdings United States

President & CEO Cybrexa Therapeutics United States

Executive Vice President, Finance & COO Cyclacel Pharmaceuticals United Kingdom

President & CEO Cyclacel Pharmaceuticals United States

Chief Executive Officer Cytodel United States

CEO Cytonus Therapeutics United States

VP Corporate Affairs Cytovia Therapeutics United States

Chairman & CEO Cytovia Therapeutics United States

Chief Executive Officer Da Volterra France

Investor Dabar Investment Associates United States

President & CEO Daré Bioscience United States

Investor DB Capital United States

VC/Corporate VC Deca Ventures United States

CEO DeckTherapeutics United States

Chief Business Officer Decoy Biosystems United States

VP, Business Development Deerfield Management Company United States

VC/Corporate VC Deerfield Management Company United States

Angel Investing DEFTA Partners United States

Venture Philanthropy Delaware Innovation Space United States

President and CEO DelMar Pharmaceuticals United States

Investment Bank Deltec Bank Bahamas

Hedge/Mutual Funds (PM, Buy-Side Research) Delwar Capital Management United States

Sell-Side Research Deutsche Bank United States

VC/Corporate VC DHVC United States

Hedge/Mutual Funds (PM, Buy-Side Research) District 2 Capital United States

Hedge/Mutual Funds (PM, Buy-Side Research) Douglas C. Lane & Associates United States

CEO Drusolv Therapeutics United States

Family Office DTB Capital Management United States

Chief Executive Officer Dyadic International United States

Chief Commercial Officer Dyadic International United States

VC/Corporate VC Dynamk Capital United States

CEO / Co-Founder Dyve Biosciences United States

Chief Operating Officer Dyve Biosciences United States

Family Office E Squared Capital Management United States

VC/Corporate VC Easton Capital United States

Hedge/Mutual Funds (PM, Buy-Side Research) Edgewood Management United States

President and CEO eFFECTOR Therapeutics United States

VC/Corporate VC EG Capital Advisors Russian Federation

CEO Eleusis United States

Vice President, Emerging Technology & Innovation Eli Lilly and Company United States

Sr. Director, Search & Evaluation - Immunology Eli Lilly and Company United States

Advisor, Search & Evaluation - Oncology Eli Lilly and Company United States

Director, Business Development Eloxx Pharmaceuticals United States

Chief Business Officer Eloxx Pharmaceuticals United States

CEO Emerald Bioscience United States

President, Co-founder and Chief Scientific Officer ENB Therapeutics United States

Investor Relations Encore Advisory United States

Chief Executive Officer Enesi Pharma United Kingdom

President, CEO & Founder Engage Therapeutics United States

Executive Vice President and Chief Operating Officer Engage Therapeutics United States

Chief Scientific Officer Engrail Therapeutics United States

President and CEO Engrail Therapeutics United States

Hedge/Mutual Funds (PM, Buy-Side Research) Ensconce Capital United States

CEO Envisagenics United States

Chief Executive Officer EpicentRx United States

CEO EpiVax Oncology United States

Chief Executive Officer Equillium United States

Family Office Esousa Holdings United States

Chief Executive Officer E-Therapeutics United Kingdom

VC/Corporate VC ETP Global Fund United States

CEO Eupraxia Pharmaceuticals Canada

Sell-Side Research EVOLUTION Life Science Partners United States

CEO Evonetix United Kingdom

CEO EVQLV United States

Angel Investing Executive Forum Angels United States

Family Office Exome Asset Management United States

President & CEO EyeGate Pharmaceuticals United States

Chief Financial Officer EyeGate Pharmaceuticals United States

VC/Corporate VC Fannin Innovation Studio United States

Family Office FC Capital United States

Hedge/Mutual Funds (PM, Buy-Side Research) First Island Capital United States

Hedge/Mutual Funds (PM, Buy-Side Research) First Seafront Fund Management China

CEO First Wave United States

Investor FMG Ventures United States

VC/Corporate VC Fortress Biotech United States

VC/Corporate VC Fountain Healthcare Partners Ireland

Family Office Foxhill Asset Management United States

Individual Investor Franklin Global Partners United States

Hedge/Mutual Funds (PM, Buy-Side Research) Frigate Capital Management United States

President, Biosciences Division FSD Pharma Canada

Executive Co-Chair & CEO FSD Pharma Canada

Capital Markets Associate FSD Pharma Canada

VC/Corporate VC Fujifilm Diosynth Biotechnologies United States

Financial Advising Gagnon Securities United States

General Manager Gain Therapeutics Switzerland

CEO GBA Group Pharma Austria

Advisor Gedeon Richter United States

President Gedeon Richter USA United States

Head, Oncology R&D Geistlich Pharma NA United States

Chief Executive Officer Geistlich Pharma North America United States

Head, Oncology Commercial Strategy Geistlich Pharma North America United States

CEO Gel4Med United States

VP of Investor Relations Genfit Pharmaceuticals United States

EVP Commercial Development Genfit SA France

CEO Genfit SA France

Executive Chairman Genisphere United States

Director, Life Sciences Georgia, USA United States

CEO Gero Singapore

SVP, Head of Corporate Communications Global Blood Therapeutics United States

VC/Corporate VC Global Founders Capital United States

Venture Philanthropy Global Neurohealth Ventures United States

CEO Glycomine United States

Chairman/CEO Glycostem Therapeutics Netherlands

Vice President, Business Development Glysantis Canada

CEO Glysantis Canada

President/CSO Gnomegen United States

Individual Investor Golden Eagle Capital Advisors United States

President & CEO Goldilocks Therapeutics United States

Hedge/Mutual Funds (PM, Buy-Side Research) Goldwater Asset Management United States

VC/Corporate VC Good Health Capital United States

Senior business development advisor Government of Quebec United States

CEO Great Bay Bio Limited Hong Kong

Executive Director Greater Zurich Area Ag United States

VC/Corporate VC GreenSky Capital Canada

Chief Executive Officer Greenwich LifeSciences United States

VC/Corporate VC Grey Sky Venture Partners United States

Senior Managing Director Griffin Securities United States

President & Head of Investment Banking H.C. Wainwright & Company United States

Associate, Investment Banking H.C. Wainwright & Company United States

Director, Healthcare Investment Banking H.C. Wainwright & Company United States

Managing Director H.C. Wainwright & Company United States

Managing Director, Investment Banking H.C. Wainwright & Company United States

vice president H.C. Wainwright & Company United States

Investment Bank H.C. Wainwright & Company United States

Sell-Side Research H.C. Wainwright & Company United States

VC/Corporate VC H.I.G. BioHealth Partners United States

Venture Philanthropy H.I.G. Capital Management United States

VC/Corporate VC H.I.G. Capital Management United States

Family Office Hannol Ventures United States

VC/Corporate VC Harbin Pharmaceutical Group China

Chief Medical Officer Harpoon Therapeutics United States

VP Finance Harpoon Therapeutics United States

Family Office Harvard Investors Group United States

Strategic Partner Headland Strategy Group United States

Family Office Health Innovative Technology Hong Kong

Royalty/Debt Financing HealthCare Royalty Partners United States

VC/Corporate VC HEDA Ventures United States

Royalty/Debt Financing Hercules Capital United States

VC/Corporate VC Hercules Capital United States

Family Office Hibiscus Bioventures United States

VC/Corporate VC HighCape Capital United States

Hedge/Mutual Funds (PM, Buy-Side Research) Highland Capital Management United States

CEO Histogen United States

Managing Director Hitech Health Ireland

Royalty/Debt Financing Horizon Technology Finance United States

Hedge/Mutual Funds (PM, Buy-Side Research) Hudson East Capital United States

Venture Philanthropy Hudson Square Capital United States

VC/Corporate VC Hyperplane United States

CEO Ichor Biologics United States

Vice President IDA Ireland United States

CEO Ilya Pharma Sweden

Senior Vice President Corporate Development Immunis.AI United States

President and CEO ImmunoMet Therapeutics United States

CEO Immunovant United States

EVP Chief Business Officer ImmunSYS United States

Chairman & CEO ImmunSYS United States

Chief Business Officer Impel NeuroPharma United States

Director, Investor Relations & Communications IMV Canada

Chief Financial Officer IMV Canada

Hedge/Mutual Funds (PM, Buy-Side Research) Inbio Ventures Russian Federation

President & CEO InCarda Therapeutics United States

Chief Executive Officer Inflection Biosciences Ireland

Product Specialist Informa United States

Investor Ingenio Therapeutics / Mayewell Capital United States

Family Office InMed Pharmaceuticals United States

Chief Financial Officer INmune Bio United States

President & CEO INmune Bio United States

VC/Corporate VC Innovent Biologics China

Investor Integrium United States

CEO InteRNA Technologies B.V. Netherlands

CEO Inthera Bioscience AG Switzerland

Hedge/Mutual Funds (PM, Buy-Side Research) inThought Research United States

CEO Intract Pharma United Kingdom

Director, R&D Intract Pharma United Kingdom

Investor Intuitive United States

Investor Inukshuk Capital United States

CEO iQure Pharma United States

Hedge/Mutual Funds (PM, Buy-Side Research) ISAR Capital Management United States

MD, Investment Banking J.P. Morgan United States

Royalty/Debt Financing J.P. Morgan United States

VC/Corporate VC J.W. Childs Associates United States

Sell-Side Research Janney Montgomery Scott United States

Director, Licensing QS Evaluation Janssen R&D United States

Sell-Side Research Jefferies United States

Chairman Jefferson Pharmaceuticals United States

Financial Advising JH Darbie & Co. United States

CEO JHL Biotech Taiwan

Investor Jiangsu Hengrui Medicine Co. China

VC/Corporate VC Jina Ventures United States

Family Office JM Cohen & Co. United States

Individual Investor Johnston Associates United States

Royalty/Debt Financing K2 HealthVentures United States

Investor Kalka Fund United States

CEO Katena Oncology United States

Principal Keynote Coaching United States

Senior Vice President of Business Development Kineta United States

President Kineta United States

Chief Business Officer Kintai Therapeutics United States

President & CEO Kintai Therapeutics United States

President Kissei America United States

CEO Kitov Pharma Israel

President Korea Drug Development Fund Korea, Republic of

Hedge/Mutual Funds (PM, Buy-Side Research) Krensavage Asset Management United States

CEO, Cofounder Kymeris Canada

Sell-Side Research Ladenburg Thalmann United States

Sell-Side Research Laidlaw & Company United States

VC/Corporate VC Laidlaw Venture Partners United States

Chairman of the Board, President and CEO Landos Biopharma United States

Founder, Chairman & CEO Lauren Sciences United States

Account Director, IR & Corporate Communications LaVoie Health Science United States

Executive Vice President & Chief Strategy Officer LaVoieHealthScience United States

President & CEO LaVoieHealthScience United States

CEO Leading BioSciences United States

Chief Financial Officer Leap Therapeutics United States

CEO Libera Bio United States

Chief Editor Life Science Connect United States

VC/Corporate VC Life Sciences Greenhouse of Central PA United States

Investor LifeNet Health United States

Hedge/Mutual Funds (PM, Buy-Side Research) LifeScience EquityPartners United States

Sell-Side Research LifeTech Capital United States

Chief Financial Officer Liminal BioSciences Canada

Chief Executive Officer Liminal BioSciences United Kingdom

Family Office Lincoln Park Capital United States

Family Office Lions Bay Capital United States

Investor Livingston United States Managing Director, Global Head of Financing and Sales Locust Walk United States

Senior Vice President Locust Walk United States

CEO and Co-Founder Locust Walk United States

Angel Investing LSWorks United States

Family Office LumeBio Korea, Republic of

VC/Corporate VC Lumira Ventures United States

Investor Lyfe Capital United States

VC/Corporate VC Lyfe Capital United States

Director MacDougall Biomedical Communications United States

Senior Vice President MacDougall Biomedical Communications United States

VC/Corporate VC Madryn Asset Management United States

Royalty/Debt Financing Madryn Asset Management United States

Family Office Magid Family Office United States

Founder & CEO MAIA Biotechnology United States

Vice Chairman Marcum United States

Senior Director of Business Development Marcum United States

Partner Marcum United States

CEO Matricelf Israel

President & CEO MaveriX Oncology United States

President & CEO MaxCyte United States

Financial Advising Maxim Group United States

Investment Bank Maxim Group United States

Sell-Side Research Maxim Group United States

Hedge/Mutual Funds (PM, Buy-Side Research) MAZ Capital Advisors United States

Angel Investing Med Pro Investors United States

CEO MediSieve United Kingdom

VC/Corporate VC Merlin Nexus United States

CEO MetVital United States

CEO Microba Australia

Investor Mid Atlantic Bio Angels United States

Chief Executive Officer MimiVax United States

SVP, Corp. Business Development Mission Pharmacal United States

Angel Investing MIT Alumni Angels of Northern California United States

VC/Corporate VC Mitsui & Co. Global Investment United States

Investor Mizuho Corporate Bank United States

Sell-Side Research Mizuho Securities United States

CEO Modra Pharmaceuticals Netherlands

CEO Mogrify United Kingdom

CEO Molecular Theranostics United States

Family Office Morgan Capital United States

Partner Morrison & Foerster United States

Partner Morrison & Foerster United States

Chief, Division of Liver Deseases Mount Sinai School of Medicine United States

Family Office Mountain Brook Capital United States

Director Mucpharm Australia

EVP, Chief Advocacy & Care Services Officer Muscular Dystrophy Association United States

Investor MV Corp Services United States

Investor MVP Capital Partners United States

SVP, Corporate Development Nascent Biotech United States Acting Director Office of Translational Alliances & Coordination National Heart, Lung, and Blood Institute United States

Investor National Holdings United States

Hedge/Mutual Funds (PM, Buy-Side Research) NauVista Capital Management United States

Chief Executive Officer Navigen Pharmaceuticals United States

Business Development / Attorney NB Health Laboratory Japan

VC/Corporate VC NCL Technology Ventures United States

CMO/CSO NDA Group United States

CEO NDA Group Sweden

Individual Investor Needham & Co. United States

Chief Medica Officer Nektar Therapeutics United States

Investment Bank Network 1 Financial Securities United States

Chief Executive Officer Neumentum United States

CEO Neurogenesis Israel

Chief Commercial & Head of Operations NeuroRx United States

Founder & CEO NeuroRx United States

Investor Neurotrope United States

Principal New Enterprise Associates United States

Hedge/Mutual Funds (PM, Buy-Side Research) New Jersey Investment Division United States

Angel Investing New York Angels United States

Family Office Newburgh Bay Capital United States

President, Chief Medical Officer NewLink Genetics United States

CMO Newron Pharmaceuticals Italy

CEO Newron Pharmaceuticals Italy

CEO NGM Biopharmaceuticals United States

VC/Corporate VC NGN Capital United States

Strategic Marketing Analyst Nikon Instruments United States

Founder, President & CSO Nirogyone Therapeutics United States

Hedge/Mutual Funds (PM, Buy-Side Research) Noble Equity Fund United States

Family Office Northlea Partners United States

CEO Notogen Canada

Acting CEO and founder Novadip Biosciences Belgium

Investor Novatio Ventures United States

CEO Novice Therapeutics United States

VC/Corporate VC Novo Ventures United States

Chief Executive Officer Now Biopharma United States

VC/Corporate VC NSIP United States

Board Member NYC Builds Bio+ United States

Financial Advising NYC MedTech/Perselson United States

Family Office Oasis Capital United States

Royalty/Debt Financing Oberland Capital Management United States

President Oligomerix United States

Chief Commercial Officer Oligomerix United States

Executive Vice President Olipass Korea, Republic of

CEO OliPass Korea, Republic of

VC/Corporate VC Omega Funds United States

Drug Discovery Business Development Director Oncodesign France

COO Oncolyze United States

President & CEO Onconova Therapeutics United States

President & CEO ONL Therapeutics United States

Chief Executive Officer Opiant Pharmaceuticals United States

Business Development Manager OPIS Italy

Global Head of Business Development OPIS Italy

Investor Oppenheimer & Co. United States

Family Office Opto Capital Group United States

Co-Founder Opus Biotech Communications United States

Hedge/Mutual Funds (PM, Buy-Side Research) Oracle Partners United States

Chief Executive Officer Oragenics United States

Chief Financial Officer Oragenics United States

Chief Executive Officer, President & Director Oramed Pharmaceuticals Israel

VC/Corporate VC Orange Grove Bio United States

Royalty/Debt Financing OrbiMed Advisors United States

VC/Corporate VC OrbiMed Advisors United States

Family Office Orchard View Capital Advisors United States

President, Chief Executive Officer and Director Orgenesis United States

Chief Executive Officer OriCiro Genomics Japan

CEO Origenis Gmbh Germany

Chief Business Officer Origenis Gmbh Germany

Chief Executive Officer Oryzon Genomics Spain

Investor Otsuka Pharmaceutical Co. United States

President and CEO Outlook Therapeutics United States

Chairman & CEO Ovid Therapeutics United States

Royalty/Debt Financing Oxford Finance United States

CEO Oxidien Pharmaceuticals United States

Royalty/Debt Financing Pacific Western Bank United States

VP of Business Development PainQx United States

CEO PainQx United States

CEO Panorama Medicine United States

VC/Corporate VC Pappas Capital United States

Chief Executive Officer Paras Biopharmaceuticals Finland Oy Finland

Chief Executive Officer Paratek Pharmaceuticals United States

Executive Director, IR and Corporate Communication Paratek Pharmaceuticals United States

Family Office Park Ave. Capital Management International United States

Investor Parkman Healthcare Partners United States

Family Office Parkville Advisors United States

CEO Pattern Pharma Canada

President and CEO PDS Biotechnology Corporation United States

Family Office Peak One Investments United States

Investor Perseverance Capital Advisors United States

Investor Petrichor Healthcare Capital Management United States

SVP & CSO, Internal Medicine Pfizer United States

Business Development Pfizer United States

Co-Founder & CEO PhagoMed Biopharma GmbH Austria

CEO Phanes Therapeutics United States

Account Manager Pharma Intelligence - Informa United States

VP, Business Development & Operations PharmaDirections United States

Royalty/Debt Financing Pharmakon Advisors United States

President & CEO Phosplatin Therapeutics United States

Chief Medical Officer Phosplatin Therapeutics United States

Executive Vice President & COO Phosplatin Therapeutics United States

Vice President of Commercialization Phosplatin Therapeutics United States

Vice President, Business Development Phosplatin Therapeutics United States

President & CEO Pipeline Therapeutics United States

Sell-Side Research Piper Sandler United States

Chief Financial Officer Polynoma United States

Chairman Polynoma United States

CSO POP Biotechnologies United States

Co-Founder / CEO Praetego United States

Investor Premier Partners Korea, Republic of

VC/Corporate VC Prevail Partners United States

Angel Investing Princeton Biopharma United States

President & CEO Principia Biopharma United States

Investor Prism Biomedical Research United States

Hedge/Mutual Funds (PM, Buy-Side Research) Promethean Capital Group United States

President & CEO Protalix Biotherapeutics Israel

CFO Protalix Biotherapeutics Israel

Founder and CEO Quadrant Biosciences United States

Investor Quan Capital China

CEO Qulab United States

Head of Business Development RallyBio United States

Sell-Side Research Raymond James United States Managing Director, Co-Head of Health Care Investment Banking Raymond James & Associates United States

Director Raymond James & Associates United States

Co Founder and President RBW Consulting United States

Chief Executive Officer Redx Pharma United Kingdom

CEO ReForm Biologics United States

Hedge/Mutual Funds (PM, Buy-Side Research) Remsen Investors United States

CEO / FOUNDER Rescue Hearing United States

Hedge/Mutual Funds (PM, Buy-Side Research) Revach Fund United States

Chief Financial Officer Rezolute United States

Founder and CEO RG+A United States

Sell-Side Research RHK Capital United States

Investment Bank RHK Capital United States

Assistant Director, Business Development RHO United States

VP Finance Ripple Therapeutics Canada

President & CEO Ripple Therapeutics Canada

Chairman and Chief Executive Officer RMJ Holdings United States

Sell-Side Research Robert W. Baird & Co. United States

President & CEO Rockwell Medical United States

CFO Rockwell Medical United States

Family Office Rolin United States

VC/Corporate VC Rosetta Capital United Kingdom

Managing Director ROTH Capital Partners United States Managing Director, Co-Head of Healthcare Investment Banking ROTH Capital Partners United States

Sell-Side Research Roth Capital Partners United States

CEO RubrYc Therapeutics United States

CSO Rumi Scientific California United States

President Russo Partners United States

Sell-Side Research RW Baird United States

Royalty/Debt Financing Sagard Holdings Canada

Chief Executive Officer Salarius Pharmaceuticals United States

President & CEO Samus Therapeutics United States

Chief Financial Officer Samus Therapeutics United States

Chief Scientific Officer Samus Therapeutics United States

Angel Investing Sandhill Angels United States President of Sandoz US and Head of North America, Sandoz Sandoz United States

Director of Communications Sandoz United States

Head Business Development CDMO | North America Sanofi US United States

Sr. Business Development Manager CDMO Sanofi US United States

VC/Corporate VC Santen Pharmaceutical Co. United States

Hedge/Mutual Funds (PM, Buy-Side Research) Sarissa Capital Management LP United States

VC/Corporate VC Satter Medical Technology Partnership United States

CEO Scancell United Kingdom

Sr. VP - Business Development & Marketing Schrocken United States

President & Chief Executive Officer Scynexis United States

VC/Corporate VC SDIC Fund Management China

Family Office Second Line Capital Management United States

Investor Sector Asset Management Norway

Chief Executive Officer Sengenics Singapore

Co-Founder & CEO SEngine Precision Medicine United States

Chief Business Officer SEngine Precision Medicine United States

Chief Executive Officer Serimmune United States

Hedge/Mutual Funds (PM, Buy-Side Research) Serrado Capital United States

Lead Director, BD&L Oncology Servier France

Investor Shanghai Henlius Biotech United States

VP, Corp. Dev, & CFO, Investor ShareVault United States

Family Office Shaw Strategic Capital United States

C Suite Executive, Board Director Shawn Tomasello Consulting United States

Chairman Shinkei Therapeutics United States

Royalty/Debt Financing Signature Bank United States

Investor Simcere Pharmaceutical Group United States

Hedge/Mutual Funds (PM, Buy-Side Research) Simrx Advisors United States

Hedge/Mutual Funds (PM, Buy-Side Research) Sio Capital Management United States

Angel Investing Sky Ventures Group United States

CEO and President SmartPharm Therapeutics United States

VC/Corporate VC Smilegate Investment Korea, Republic of

Principal SMP Communications United States

VC/Corporate VC Sofinnova United States

VC/Corporate VC Solar Capital Partners United States

President & CEO Soligenix United States

Venture Philanthropy Sound Affects United States

Founder Sparrow Pharmaceuticals United States

Hedge/Mutual Funds (PM, Buy-Side Research) Special Situations Funds United States

Angel Investing SPRIM Ventures Singapore

Investor SR One United States

VC/Corporate VC Starlink Capital United States

Founder and President Stemsynergy Therapeutics United States

CEO Step Pharma France

Director, Life Sciences Sterling Bay United States

VC/Corporate VC Stonehenge Capital United States

VC/Corporate VC Strathspey Crown United States

Director, Investor Relations Summit Therapeutics United States

Chief Executive Officer Summit Therapeutics United Kingdom

Investor Sun Pharmaceuticals United States

Managing Director SunTrust Robinson Humphrey United States

Investor SunTrust Robinson Humphrey United States

Hedge/Mutual Funds (PM, Buy-Side Research) Surveyor Capital United States

Chief Executive Officer Sutro Biopharma United States

Trade Commissioner Swiss Business Hub USA United States

Chief Business Officer SynDevRx United States

Client Engagement Lead, Syneos One Syneos Health United States

President & CEO Synlogic United States

VP of IR & Corporate Communications Synlogic United States

Director, Investor Relations Synthetic Biologics United States

CEO & CFO Synthetic Biologics United States

Founder & CEO Synthis United States

VC/Corporate VC Taiho Ventures United States

VC/Corporate VC Tang Capital Management United States

Hedge/Mutual Funds (PM, Buy-Side Research) Tang Capital Management United States

CEO TargetGene Biotechnologies Israel

VC/Corporate VC Tectonic Capital United States

Director Finance TenNor Therapeutics China

CEO TenNor Therapeutics China

President & COO Teon Therapeutics United States

Family Office Terra Stone Capital United States

CEO Terran Biosciences United States

Chief Business Officer Terran Biosciences United States

Chairman & CEO Tetra Therapeutics United States

President, Chief Executive Officer and Director TFF Pharmaceuticals United States

Angel Investing The Abraham Group United States

Hedge/Mutual Funds (PM, Buy-Side Research) The Anson Group Canada

Family Office The Astrologers Fund United States

Sell-Side Research The Benchmark Company United States

Investor The Center for Performance Investing United States

Investor The Engine United States

Investment Associate The Global Emerging Market (GEM) Group United States

Venture Philanthropy The Leukemia & Lymphoma Society United States

Hedge/Mutual Funds (PM, Buy-Side Research) The Lind Partners United States

Managing Partner The Money Channel NYC United States

Chief Business Development Officer The Money Channel NYC United States

Chairman of the Board TheraTarget United States

Sell-Side Research Think Equity United States

Administrative Dept. Thoth Science Korea, Republic of

Executive Vice President And COO Tiberend Strategic Advisors United States

President & CEO Tiberend Strategic Advisors United States

CSO TnA Therapeutics United States

Investor Tokyo Stock Exchange Japan

Chief Executive Officer TONIX Pharmaceuticals United States

Managing Director Torreya United States

Partner Torreya United States

VC/Corporate VC Tosoh USA United States

Angel Investing Treehill Principal Strategies United Kingdom

Strategic Partnerships Manager TrialSpark United States

Angel Investing Tri-Medix United States

Chief Scientific Officer TriSalus Life Sciences United States

President & CEO TriSalus Life Sciences United States

Chief Executive Officer and Chairman TrovaGene United States

Chief Scientific Officer TrovaGene United States

Investor Tryphon Capital Advisors United States

Chief Business Officer Tulane University United States

Senior Vice President Biopharma BD twoXAR United States

CEO twoXAR United States

Technical Specialist & Entrepreneurial Lead University of Exeter United Kingdom

Endowment/Foundation University of Notre Dame United States

Manager, Strategic Industry Ventures University of Texas, MD Anderson Cancer Center United States

Hedge/Mutual Funds (PM, Buy-Side Research) Unterberg Capital United States

Family Office Upstream Partners United States

Hedge/Mutual Funds (PM, Buy-Side Research) V2m Life Sciences Fund United States

Hedge/Mutual Funds (PM, Buy-Side Research) ValQuest United States

Hedge/Mutual Funds (PM, Buy-Side Research) Varana Capital United States

CBO Vaximm AG Switzerland

CEO VBL Therapeutics Israel

Family Office Vector Capital United States

Angel Investing Vector Point Ventures United States

Family Office Vector Resource Funds United States

President and CEO VenatoRx Pharmaceuticals United States

Chief Business Officer VenatoRx Pharmaceuticals United States

Business Development Manager Venture Valuation Switzerland

Founder & CEO VerImmune United States

CEO Verum Diagnostics United States

Founder & CSO Verum Diagnostics United States

President & CEO Vida Strategic Partners United States

President & CEO viDA Therapeutics Canada

Director Vida Ventures United States

Managing Director Vida Ventures United States

Senior Strategic Advisor Vigeo Therapeutics United States

Senior VP Finance Viking Therapeutics United States

Chief Financial officer Viracta Therapeutics United States

Family Office Vista Capital Advisors United States

Hedge/Mutual Funds (PM, Buy-Side Research) Vista Point Capital United States

CEO Vita Therapeutics United States

Investor Voya Financial United States

President and CEO Vyome Therapeutics United States

Investor W Global Capital United States

Investment Bank Wallachbeth Capital United States

Sell-Side Research WBB Securities United States

Family Office Western International United States

VC/Corporate VC Westlake Ventures United States

CEO Westwood Therapeutics United States

Hedge/Mutual Funds (PM, Buy-Side Research) Wexford Capital United States

Family Office Wick Capital Partners United States

Investor Wolpert Associates United States

Executive Director Women In Bio United States

Co-Founder, President & CEO X-Biotix Therapeutics United States

Hedge/Mutual Funds (PM, Buy-Side Research) Xeraya Capital Life Venture Malaysia

Family Office Xerion Investments United States

President & CEO XyloCor Therapeutics United States

Hedge/Mutual Funds (PM, Buy-Side Research) YA Global United States

Blavatnik Fellow Yale University United States

Endowment/Foundation Yale University, Office of Cooperative Research United States

CEO Yamo Pharmaceuticals United States

Individual Investor YlLGA Management Services Israel

Independent Research Firm Young America Capital United States

Sell-Side Research Zacks Small Cap Research United States

VC/Corporate VC Zeniths Capital China

President and CEO Zikani Therapeutics United States

Investor ZJ Future United States